Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.52163 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.45359 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.46264 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41473 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.37921 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.51634 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.47584 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.44379 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.43359 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.45374 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.45146 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43826 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46156 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.45083 | 19 |